real-world insights on pembrolizumab for er-low triple-negative breast cancer
Published 1 month ago • 23 plays • Length 2:46Download video MP4
Download video MP3
Similar videos
-
4:20
keynote-522: 5-year follow-up of pembrolizumab in triple-negative breast cancer
-
2:07
keynote-355: pembrolizumab in triple-negative breast cancer
-
5:24
real-world outcomes among patients with metastatic triple-negative breast cancer
-
2:46
ameera-3: amcenestrant does not improve pfs in er /her2- breast cancer
-
0:50
serds for patients with er /her2- breast cancer
-
1:51
ameera-3: serd for er her2- breast cancer
-
17:05
episode 73 the clinical and biological significance of er “low positive” breast cancer
-
2:02
breast cancer types, receptor status, and how this shapes treatment
-
2:22
i had er positive breast cancer. now i have triple-negative breast cancer. how is this possible?
-
0:46
learn about triple-negative breast cancer and its unique challenges 🎗️🔬
-
1:00:32
breast cancer | meet the professor: optimizing the management of er-positive and triple-negative ...
-
0:47
atezolizumab for tnbc
-
7:42
the complexities of battling triple-negative breast cancer
-
0:51
what about triple negative hormone negative h er negative cancer?
-
0:54
tripple negative breast cancer
-
2:35
what does the future hold for serds in er breast cancer?
-
0:30
the role of serds in the treatment landscape of patients with er /her2- breast cancer
-
3:33
eribulin in metastatic tnbc: real-world data
-
0:53
eleanor: real-world study of extended adjuvant neratinib in her2 /hr early breast cancer